A groundbreaking study reveals that getting vaccinated against shingles may lower the risk of developing dementia by 20% over seven years. This research highlights the potential of immunization in protecting brain health as we age.
Recent research suggests that Ozempic and similar GLP-1 drugs may lower the risk of dementia in those with type 2 diabetes. Discover how these drugs are being tested for dementia prevention!
A groundbreaking study from Wales reveals that receiving the shingles vaccine may reduce the risk of developing dementia by 20%. This unexpected finding could change how we approach dementia prevention and treatment.
A new study reveals that shingles vaccination may reduce the risk of dementia by 20% in older adults. Discover how this common vaccine could protect aging brains and its implications for dementia prevention.
A groundbreaking study reveals that the shingles vaccine may reduce the risk of developing dementia by 20% in older adults. This discovery highlights the importance of vaccinations for brain health as we age.
Study shows that new Alzheimer's drugs lecanemab and donanemab can significantly extend the period of independent living for patients with early-stage Alzheimer's disease, highlighting potential benefits and risks.
